Steinhart Richard I
Visual SEC Form 4 history across 2 companies, 3 transactions and 2 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No latest transaction fact is available.
No open-market insider purchase is available.
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ATNM | Steinhart Richard I | DIR | grant | 94.2k | $0 | A | — | 09/04 | 09/02 | |
| ATNM | Steinhart Richard I | DIR | grant | 62.8k | $0 | A | — | 09/04 | 09/02 | |
| BTAI | Steinhart Richard I | CFO | grant | 70.0k | $0 | A | −28.2% | 01/06 | 01/01 |
Steinhart Richard I Insider Activity FAQ
SEC Form 4 context
Who is Steinhart Richard I?
Steinhart Richard I is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001293789.
Which companies has Steinhart Richard I reported transactions for?
Actinium Pharmaceuticals, Inc., BioXcel Therapeutics, Inc.
When was Steinhart Richard I's latest insider buy?
No open-market insider purchase is available for this period.
When was Steinhart Richard I's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.